Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hemoglobinopathies Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hemoglobinopathies Drugsmarket, defines the market attractiveness level of Hemoglobinopathies Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hemoglobinopathies Drugs industry, describes the types of Hemoglobinopathies Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hemoglobinopathies Drugs market and the development prospects and opportunities of Hemoglobinopathies Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hemoglobinopathies Drugs market in Chapter 13.
By Player:
Gamida Cell
Sangamo BioSciences Inc
Emmaus Life Sciences, Inc
Pfizer Inc
Celgene Corporation
Mast Therapeutics
Global Blood Therapeutics Inc
Alnylam Pharmaceuticals
Prolong Pharmaceuticals
Biogen Idec
Genetix Pharmaceuticals/Bluebird Bio
HemaQuest Pharmaceuticals
By Type:
Thalassemia Therapy
Sickle Cell Disease(SCD) Therapy
Other Therapy
By End-User:
Alpha Thalassemia
Beta thalassemia
Sickle Cell Disease
Hb Variants Diseases
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hemoglobinopathies Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hemoglobinopathies Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hemoglobinopathies Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hemoglobinopathies Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hemoglobinopathies Drugs Market Analysis and Outlook to 2022
-
7.1 Global Hemoglobinopathies Drugs Consumption (2017-2022)
-
7.2 United States Hemoglobinopathies Drugs Consumption (2017-2022)
-
7.3 Europe Hemoglobinopathies Drugs Consumption (2017-2022)
-
7.4 China Hemoglobinopathies Drugs Consumption (2017-2022)
-
7.5 Japan Hemoglobinopathies Drugs Consumption (2017-2022)
-
7.6 India Hemoglobinopathies Drugs Consumption (2017-2022)
-
7.7 South Korea Hemoglobinopathies Drugs Consumption (2017-2022)
8 Region and Country-wise Hemoglobinopathies Drugs Market Analysis and Outlook to 2028
-
8.1 Global Hemoglobinopathies Drugs Consumption Forecast (2022-2028)
-
8.2 United States Hemoglobinopathies Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Hemoglobinopathies Drugs Consumption Forecast (2022-2028)
-
8.4 China Hemoglobinopathies Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Hemoglobinopathies Drugs Consumption Forecast (2022-2028)
-
8.6 India Hemoglobinopathies Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Hemoglobinopathies Drugs Consumption Forecast (2022-2028)
9 Global Hemoglobinopathies Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Hemoglobinopathies Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Thalassemia Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Sickle Cell Disease(SCD) Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Hemoglobinopathies Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Alpha Thalassemia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Beta thalassemia Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Sickle Cell Disease Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Hb Variants Diseases Consumption and Growth Rate (2017-2022)
10 Global Hemoglobinopathies Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Hemoglobinopathies Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Thalassemia Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Sickle Cell Disease(SCD) Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hemoglobinopathies Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Alpha Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Beta thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Sickle Cell Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Hb Variants Diseases Consumption Forecast and Growth Rate (2022-2028)
11 Global Hemoglobinopathies Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hemoglobinopathies Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hemoglobinopathies Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hemoglobinopathies Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hemoglobinopathies Drugs Market Competitive Analysis
-
14.1 Gamida Cell
-
14.1.1 Gamida Cell Company Details
-
14.1.2 Gamida Cell Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gamida Cell Hemoglobinopathies Drugs Product and Service
-
14.2 Sangamo BioSciences Inc
-
14.2.1 Sangamo BioSciences Inc Company Details
-
14.2.2 Sangamo BioSciences Inc Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sangamo BioSciences Inc Hemoglobinopathies Drugs Product and Service
-
14.3 Emmaus Life Sciences, Inc
-
14.3.1 Emmaus Life Sciences, Inc Company Details
-
14.3.2 Emmaus Life Sciences, Inc Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Emmaus Life Sciences, Inc Hemoglobinopathies Drugs Product and Service
-
14.4 Pfizer Inc
-
14.4.1 Pfizer Inc Company Details
-
14.4.2 Pfizer Inc Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Inc Hemoglobinopathies Drugs Product and Service
-
14.5 Celgene Corporation
-
14.5.1 Celgene Corporation Company Details
-
14.5.2 Celgene Corporation Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Celgene Corporation Hemoglobinopathies Drugs Product and Service
-
14.6 Mast Therapeutics
-
14.6.1 Mast Therapeutics Company Details
-
14.6.2 Mast Therapeutics Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mast Therapeutics Hemoglobinopathies Drugs Product and Service
-
14.7 Global Blood Therapeutics Inc
-
14.7.1 Global Blood Therapeutics Inc Company Details
-
14.7.2 Global Blood Therapeutics Inc Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Global Blood Therapeutics Inc Hemoglobinopathies Drugs Product and Service
-
14.8 Alnylam Pharmaceuticals
-
14.8.1 Alnylam Pharmaceuticals Company Details
-
14.8.2 Alnylam Pharmaceuticals Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Alnylam Pharmaceuticals Hemoglobinopathies Drugs Product and Service
-
14.9 Prolong Pharmaceuticals
-
14.9.1 Prolong Pharmaceuticals Company Details
-
14.9.2 Prolong Pharmaceuticals Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Prolong Pharmaceuticals Hemoglobinopathies Drugs Product and Service
-
14.10 Biogen Idec
-
14.10.1 Biogen Idec Company Details
-
14.10.2 Biogen Idec Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Biogen Idec Hemoglobinopathies Drugs Product and Service
-
14.11 Genetix Pharmaceuticals/Bluebird Bio
-
14.11.1 Genetix Pharmaceuticals/Bluebird Bio Company Details
-
14.11.2 Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Product and Service
-
14.12 HemaQuest Pharmaceuticals
-
14.12.1 HemaQuest Pharmaceuticals Company Details
-
14.12.2 HemaQuest Pharmaceuticals Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 HemaQuest Pharmaceuticals Hemoglobinopathies Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hemoglobinopathies Drugs
-
Figure Hemoglobinopathies Drugs Picture
-
Table Global Hemoglobinopathies Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hemoglobinopathies Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hemoglobinopathies Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hemoglobinopathies Drugs Consumption by Country (2017-2022)
-
Figure United States Hemoglobinopathies Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Hemoglobinopathies Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Hemoglobinopathies Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Hemoglobinopathies Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Hemoglobinopathies Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hemoglobinopathies Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hemoglobinopathies Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Hemoglobinopathies Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hemoglobinopathies Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hemoglobinopathies Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hemoglobinopathies Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hemoglobinopathies Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hemoglobinopathies Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thalassemia Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Sickle Cell Disease(SCD) Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Other Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Alpha Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure Global Beta thalassemia Consumption and Growth Rate (2017-2022)
-
Figure Global Sickle Cell Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Hb Variants Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Thalassemia Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sickle Cell Disease(SCD) Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alpha Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Beta thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sickle Cell Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hb Variants Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hemoglobinopathies Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hemoglobinopathies Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Gamida Cell (Foundation Year, Company Profile and etc.)
-
Table Gamida Cell Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gamida Cell Hemoglobinopathies Drugs Product and Service
-
Table Sangamo BioSciences Inc (Foundation Year, Company Profile and etc.)
-
Table Sangamo BioSciences Inc Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo BioSciences Inc Hemoglobinopathies Drugs Product and Service
-
Table Emmaus Life Sciences, Inc (Foundation Year, Company Profile and etc.)
-
Table Emmaus Life Sciences, Inc Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emmaus Life Sciences, Inc Hemoglobinopathies Drugs Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Hemoglobinopathies Drugs Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Hemoglobinopathies Drugs Product and Service
-
Table Mast Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Mast Therapeutics Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mast Therapeutics Hemoglobinopathies Drugs Product and Service
-
Table Global Blood Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Global Blood Therapeutics Inc Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Global Blood Therapeutics Inc Hemoglobinopathies Drugs Product and Service
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals Hemoglobinopathies Drugs Product and Service
-
Table Prolong Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Prolong Pharmaceuticals Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prolong Pharmaceuticals Hemoglobinopathies Drugs Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Hemoglobinopathies Drugs Product and Service
-
Table Genetix Pharmaceuticals/Bluebird Bio (Foundation Year, Company Profile and etc.)
-
Table Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Product and Service
-
Table HemaQuest Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table HemaQuest Pharmaceuticals Hemoglobinopathies Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table HemaQuest Pharmaceuticals Hemoglobinopathies Drugs Product and Service
-
